Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C18H22O11 |
| Molecular Weight | 414.3607 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 9 / 9 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=O)OCC1=C[C@@H]2OC(=O)C3=CO[C@@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@H]1[C@H]23
InChI
InChIKey=IBIPGYWNOBGEMH-DILZHRMZSA-N
InChI=1S/C18H22O11/c1-6(20)25-4-7-2-9-12-8(16(24)27-9)5-26-17(11(7)12)29-18-15(23)14(22)13(21)10(3-19)28-18/h2,5,9-15,17-19,21-23H,3-4H2,1H3/t9-,10+,11+,12-,13+,14-,15+,17-,18-/m0/s1
| Molecular Formula | C18H22O11 |
| Molecular Weight | 414.3607 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 9 / 9 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/26710167Curator's Comment: Description was created based on several sources, including
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26710167
Curator's Comment: Description was created based on several sources, including
Asperuloside, an iridoid glycoside found in Herba Paederiae, is a component from traditional Chinese herbal medicine. Asperuloside is extracted from many traditional Chinese medicinal plants, including Herba Paederiae, Asperula odorata, Goldhair Hedyotis Herb and Hedyotis diffusa. It has been proved that there are many kinds of pharmacological effects such as anti-tumor and anti-obesity activities. Asperuloside can significantly downregulate tumor necrosis factor alpha (TNF-α), interleukin (IL)-1β, and IL-6 levels in vitro and in vivo, and treatment with asperuloside significantly reduced the lung wet-to-dry weight, histological alterations and myeloperoxidase activity in a murine model of LPS-induced acute lung injury (ALI). Asperuloside exerts its anti-inflammatory effect in correlation with inhibition of a pro-inflammatory mediator through suppressing nuclear factor kappa-B (NF-κB) nuclear translocation and MAPK phosphorylation. Asperuloside can be a potential treatment for ALI and can be used as a clinical anti-infective drug.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: GO:0000165 Sources: https://www.ncbi.nlm.nih.gov/pubmed/26710167 |
|||
Target ID: GO:0006629 |
|||
Target ID: Phosphatidylinositol-3-kinase Sources: https://www.ncbi.nlm.nih.gov/pubmed/7872663 |
2.0 µM [IC50] | ||
Target ID: CHEMBL4984 Sources: https://www.ncbi.nlm.nih.gov/pubmed/16508180 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26710167
20, 40, and 80 mg/kg, given intraperitoneally
Route of Administration:
Intraperitoneal
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26710167
Asperuloside ((20–80 mg/L) significantly downregulates tumor necrosis factor alpha (TNF-α), interleukin (IL)-1β, and IL-6 levels in RAW 264.7 cells
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:15:08 GMT 2025
by
admin
on
Mon Mar 31 19:15:08 GMT 2025
|
| Record UNII |
V3CFI02X39
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
238-137-5
Created by
admin on Mon Mar 31 19:15:08 GMT 2025 , Edited by admin on Mon Mar 31 19:15:08 GMT 2025
|
PRIMARY | |||
|
DTXSID70878339
Created by
admin on Mon Mar 31 19:15:08 GMT 2025 , Edited by admin on Mon Mar 31 19:15:08 GMT 2025
|
PRIMARY | |||
|
84298
Created by
admin on Mon Mar 31 19:15:08 GMT 2025 , Edited by admin on Mon Mar 31 19:15:08 GMT 2025
|
PRIMARY | |||
|
14259-45-1
Created by
admin on Mon Mar 31 19:15:08 GMT 2025 , Edited by admin on Mon Mar 31 19:15:08 GMT 2025
|
PRIMARY | |||
|
31760
Created by
admin on Mon Mar 31 19:15:08 GMT 2025 , Edited by admin on Mon Mar 31 19:15:08 GMT 2025
|
PRIMARY | |||
|
V3CFI02X39
Created by
admin on Mon Mar 31 19:15:08 GMT 2025 , Edited by admin on Mon Mar 31 19:15:08 GMT 2025
|
PRIMARY | |||
|
m2104
Created by
admin on Mon Mar 31 19:15:08 GMT 2025 , Edited by admin on Mon Mar 31 19:15:08 GMT 2025
|
PRIMARY | Merck Index |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |